Nine out of ten unvaccinated people exposed will contract it.
Em um mundo onde fronteiras não detêm vírus, um menino de três anos chegou ao sul do Brasil vindo do Paquistão carregando o sarampo — uma doença que o país havia quase conseguido apagar de seu território. A Organização Mundial da Saúde observa com preocupação o ressurgimento global da doença, lembrando que a proteção coletiva é tão frágil quanto a taxa de vacinação mais baixa de uma comunidade. O caso isolado não é a ameaça em si; é o espelho que revela o quanto a eliminação de uma doença exige vigilância permanente, geração após geração.
- O sarampo avança globalmente — México, EUA, Reino Unido, Portugal e Argentina registraram alertas recentes, e uma criança de 19 meses morreu na província argentina de Salta.
- No Brasil, um menino de três anos vindo do Paquistão confirmou o primeiro caso no país desde junho de 2022, ameaçando diretamente o processo de recertificação de eliminação da doença.
- A transmissibilidade brutal do vírus — nove em cada dez não vacinados expostos contraem a doença — transforma cada caso importado em potencial gatilho de surto.
- Autoridades do Rio Grande do Sul reagiram com rapidez: barreiras de vacinação seletiva foram montadas ao redor da família, vizinhos e profissionais de saúde que atenderam a criança.
- O país tenta reconstruir sua credibilidade sanitária após o surto de 2017-2018, que infectou mais de 40 mil pessoas e custou a certificação internacional de eliminação do sarampo.
No último dia 27 de dezembro, um menino de três anos desembarcou em Rio Grande, no extremo sul do Brasil, vindo do Paquistão — país onde o sarampo ainda circula livremente. O diagnóstico confirmado pelas autoridades de saúde do Rio Grande do Sul não era apenas um caso clínico: era um sinal de alerta que ecoou do nível local até a Organização Mundial da Saúde, que já vinha monitorando o avanço global da doença.
O contexto tornava o episódio ainda mais grave. Nas semanas anteriores, México, Estados Unidos, Reino Unido e Portugal haviam emitido alertas sanitários. Na Argentina, uma criança de 19 meses havia morrido de sarampo na província de Salta. O vírus, um dos mais contagiosos já identificados pela medicina, não respeita fronteiras — e o Brasil sabia disso por experiência própria.
O país havia perdido sua certificação internacional de eliminação do sarampo após os surtos de 2017 e 2018, que infectaram mais de 40 mil pessoas. Desde junho de 2022, nenhum caso havia sido confirmado em solo brasileiro, e o caminho para a recertificação estava sendo cuidadosamente construído. A chegada do menino paquistanês colocou esse esforço em risco.
A resposta das autoridades foi imediata: barreiras de vacinação seletiva foram estabelecidas ao redor da família, dos vizinhos e dos profissionais de saúde que atenderam a criança. O menino se recuperava bem; seus familiares não apresentavam sintomas. O município passou a monitorar qualquer febre, erupção cutânea ou conjuntivite que chegasse às unidades de saúde.
Renato Kfouri, vice-presidente da Sociedade Brasileira de Imunizações, explicou o que estava em jogo: o sarampo atinge com mais força crianças menores de cinco anos, imunossuprimidos e desnutridos, e se transmite pelo ar com uma eficiência assustadora. A vacina tríplice viral — gratuita no sistema público — era a única barreira confiável. O perigo real não era aquele caso único, mas a possibilidade de que ele se tornasse muitos. A eliminação de uma doença, lembrou Kfouri, é uma conquista que precisa ser renovada todos os dias.
The health authorities in Rio Grande do Sul, Brazil's southernmost state, confirmed what they had feared: a three-year-old boy who arrived in the port city of Rio Grande on December 27th, traveling from Pakistan, carried measles. The child had come from a country where the virus circulates freely, where it remains endemic. This single case, imported across an ocean, set off alarms that rippled from local clinics to the World Health Organization itself.
The timing was not coincidental. Across the globe, measles was surging. Mexico, the United States, the United Kingdom, and Portugal had all issued health alerts in recent weeks. In Argentina's Salta province, a nineteen-month-old child had died from the disease. The World Health Organization was sounding the alarm: measles cases were climbing worldwide, and the virus remained one of the most transmissible pathogens known to medicine. If one person contracted it, nearly everyone around them would catch it too—unless they had been vaccinated.
Brazil's situation was precarious. The country had once held certification from international health bodies proving it had eliminated measles from its territory. That was 2016. Then came 2017 and 2018, when a massive outbreak swept through the nation, infecting more than forty thousand people. The certification was revoked. Brazil became, once again, a country where measles could spread unchecked. For nearly six years now, since June 2022, there had been no confirmed cases on Brazilian soil. The country was working toward recertification, trying to prove it had regained control. The arrival of this child from Pakistan threatened that fragile progress.
The response was swift. Rio Grande do Sul's health surveillance center issued an alert. Selective vaccination barriers were erected around the boy's family, his neighbors, and the healthcare workers who had treated him. The child was recovering well. His family members showed no symptoms. The municipality began monitoring every fever, every rash, every cough or runny nose or conjunctivitis that came through its clinics, searching for signs that the virus had jumped to someone else.
The state's health secretariat reminded the public of what had always been true: the triple viral vaccine, protecting against measles, rubella, and mumps, was free through Brazil's public health system. Children needed two doses—one at twelve months, another at fifteen months. Adults up to age fifty-nine needed at least one dose. Healthcare workers needed two, regardless of age. In emergency situations like this one, vaccination could be offered to anyone older than six months.
Renato Kfouri, vice president of Brazil's immunization society, explained the stakes to journalists. Measles was not a minor illness. It was an acute viral infection that struck hardest at children under five, at people with weakened immune systems, at the malnourished. It spread through the air—through coughs, sneezes, the simple act of speaking. Nine out of every ten unvaccinated people exposed to the virus would contract it. The disease had been controlled in Brazil once. It could be again, but only if vaccination rates stayed high and surveillance remained vigilant. The real danger was not this one imported case. It was the possibility that it would spark a chain of transmission, that it would become many cases, that it would become another outbreak.
Kfouri acknowledged that the alert from Rio Grande do Sul was justified. This was a reminder of how quickly the world had become connected, how a virus could travel on an airplane from a place where it was endemic to a place trying to prove it was not. The work of elimination was not finished. It was ongoing, fragile, dependent on the willingness of millions of parents to bring their children to clinics, on the capacity of health systems to track every suspicious fever, on the international cooperation that allowed one country to learn from another's experience. Brazil was still seeking recertification. This case, contained and monitored as it was, had just made that path harder.
Citações Notáveis
Measles is one of the most transmissible diseases. If one person is infected, nearly everyone around them will catch it if they are not vaccinated.— World Health Organization
This imported case reminds us of the importance of vigilance—to prevent a single case from multiplying into secondary cases and a new outbreak.— Renato Kfouri, vice president of Brazil's immunization society
A Conversa do Hearth Outra perspectiva sobre a história
Why does a single imported case matter so much? The child is recovering, his family has no symptoms.
Because measles doesn't stay contained. One unvaccinated person in a room with ten others infects nine of them. One case becomes ten becomes a hundred. Brazil lost its elimination status once already, after forty thousand cases in 2017 and 2018. They've been trying to rebuild that certification for six years. This case is a test of whether their surveillance system works, whether their vaccination coverage is actually high enough.
What makes measles so different from other diseases?
It's almost perfectly efficient at spreading. If you're not vaccinated and you're exposed, you'll almost certainly get it. It travels through the air—a cough, a sneeze. And it's most dangerous to the people least able to fight it: babies, immunocompromised people, malnourished children. A nineteen-month-old in Argentina just died from it.
So the real problem is vaccination rates?
That's part of it. But it's also surveillance. You have to catch cases early, isolate them, vaccinate everyone around them before the virus spreads further. Rio Grande do Sul did that here—they found the case, they vaccinated the contacts, they're monitoring the community. But that only works if your system is strong enough to catch the next case, and the one after that.
Why is Pakistan relevant to Brazil?
Because the virus is endemic there. It circulates freely. A child travels from an endemic country to a country trying to prove it's eliminated the disease. That's the vulnerability of the modern world. You can't eliminate a disease in one country if it's still circulating in others.
What does recertification actually mean?
It means proving to international health bodies that you've eliminated the virus from your territory, that you have the surveillance systems and vaccination coverage to keep it out. Brazil had that once. They want it back. But one imported case, if it spreads, could set them back years.